Immune Therapeutics Inc. Spinoff Cytocom, Inc. to take part in Biotech and HC Wainwright BioConnect 2021 Exhibition During “JP Morgan 2021 Week”

WINTER PARK, FL, Jan. 11, 2021 (GLOBE NEWSWIRE) – Immune Therapeutics, Inc. announced. (Ticker: IMUN) today announced that Cytocom, Inc., a company that acquired Immune in 2014, is participating in the Biotech Digital Showcase and HC Wainwright BioConnect. Both events are almost exclusive and are co-recorded with the 39th Annual JP Morgan Healthcare Conference 2021.

Details of the events are as follows:
Biotech digital display
Date: January 11-15, 2021
Registration: https://informaconnect.com/biotech-showcase/registration-options/

HC Wainwright BioConnect Conference 2021
Date: January 11-14, 2021
Registration: https://hcwevents.com/bioconnect/#

For more information on Cytocom and their involvement go to their website at www.Cytocom.com.

Immune Therapeutics:
(888) 613-8802 
www.immunetherapeutics.com

.Source